GeneDx Holdings (WGS) Asset Writedowns and Impairment (2021 - 2026)
GeneDx Holdings (WGS) posted quarterly Asset Writedowns and Impairment of $31.3 million for Q1 2026, up 20683.55% quarter-over-quarter from -$152000.0 in Q4 2025.
GeneDx Holdings (WGS) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Asset Writedowns and Impairment for 6 consecutive years, with $31.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $31.3 million; the TTM figure through Mar 2026 stood at $31.3 million (up 22937.23% YoY), while the FY2023 annual figure was $10.4 million, down 95.05% from the prior year.
- Asset Writedowns and Impairment advanced to $31.3 million in Q1 2026 per WGS's latest filing, from -$152000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $174.5 million in Q4 2022 and bottomed at -$152000.0 in Q4 2025.
- Historically, Asset Writedowns and Impairment has averaged $21.6 million across 5 years, with a median of $83000.0 in 2022.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment surged 15652.58% — and 2024, when it slumped 98.11%.
- GeneDx Holdings' Asset Writedowns and Impairment stood at $174.5 million in 2022, then plunged by 95.25% to $8.3 million in 2023, then slumped by 101.65% to -$137000.0 in 2024, then dropped by 10.95% to -$152000.0 in 2025, then jumped by 20683.55% to $31.3 million in 2026.
- Business Quant data shows WGS's Asset Writedowns and Impairment at $31.3 million in Q1 2026, -$152000.0 in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.29 Mn |
| Mar 31, 2026 | 31.29 Mn |
| Dec 31, 2025 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Sep 30, 2023 | 8.28 Mn |
| Sep 30, 2023 | 8.28 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 174.50 Mn |
| Dec 31, 2022 | 174.50 Mn |
| Mar 31, 2022 | 43,000.00 |
| Mar 31, 2022 | 43,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Dec 31, 2021 | 1.01 Mn |